EUCTR2006-005667-26-GBActive, not recruitingPhase 1
A randomised, placebo controlled trial of levobupivacaine or the combination of levobupivacaine and clonidine when administered as a sciatic perineural infusion for the prevention of phantom limb pain and cardiac morbidity after lower limb amputation - Incidence of phantom limb pain after lower limb amputation
inewells Hospital0 sites300 target enrollmentStarted: April 17, 2007Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 300
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
Inclusion Criteria
- •All patients presenting for elective lower limb amputation will be approached for recruitement to this study.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Patients excluded from the study will be those with signs of cardiac failure (3rd heart sound, lung crepitations), hypovolaemia, respiratory failure, presence of seizures, dementia, or encephalopathy, and patients with any terminal illness with a life expectancy < 3 months
Investigators
Similar Trials
Completed
Not Applicable
A randomised, placebo controlled trial of levobupivacaine or the combination of levobupivacaine and clonidine when administered as a sciatic perineural infusion for the prevention of phantom limb pain after lower limb amputatioPhantom limb pain in amputation casesNervous System DiseasesNerve root and plexus disordersISRCTN31319378HS Tayside (UK)180
Completed
Not Applicable
A randomised placebo-controlled trial of epirubicin and quinidine in patients with advanced breast cancerBreastCancerISRCTN23196537Cancer Research UK (CRUK) (UK)
Active, not recruiting
Phase 1
A Trial of Psilocybin in Clinical Depression Resistant to Standard TreatmentsEUCTR2018-003573-97-GBKing's College London60
Completed
Phase 3
A randomised controlled trial of the efficacy of a carrageenan nasal spray when taken during a cold in reducing asthma exacerbations as measured by the asthma control questionnaire.Asthma exacerbation during a coldColdsRespiratory - AsthmaInfection - Studies of infection and infectious agentsACTRN12615001166561Julian Crane361
Active, not recruiting
Phase 1
A study testing whether the cholesterol-lowering medicine fenofibrate can slow down the progression of diabetic eye diseaseEUCTR2016-002656-24-GBniversity of Oxford (Clinical Trials and Research Governance))1,060